The benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has followed global markets lower today and in afternoon trade the index is down 1.3% to 5,710 points.
Despite the majority of the market being in the red, a number of shares have managed to climb higher today. Here’s why they have defied the market:
The Appen Ltd (ASX: APX) share price has rocketed 23% to $3.17 after the exciting tech company upgraded its full-year guidance. Increasing demand for its high quality data for machine learning-based product development means management expects annual EBITDA growth of between 40% and 50%. Previous guidance was for mid to high teen growth. Even after its surge today, I think Appen could be a great buy and hold investment.
The Fairfax Media Limited (ASX: FXJ) share price is up almost 7% to $1.24 after a new suitor emerged. Hellman & Friedman LLC has launched a takeover offer of between $1.225 and $1.25 per share in cash, outbidding the TPG Group consortium. Shareholders will no doubt hope that this is the start of a bidding war.
The Impedimed Limited (ASX: IPD) share price has surged 34% to 72.5 cents after the medical technology company released the results of its L-Dex study. According to the release 596 patients using its L-Dex product demonstrated extremely low rates of chronic, clinically significant breast cancer related lymphoedema.
The Perseus Mining Limited (ASX: PRU) share price has jumped 2.5% to 31.2 cents following a rise in the gold price. With global markets sinking lower amid the Trump-Comey controversy, investors have taken flight to safe havens. This led to the spot gold price climbing to a two-week high of US$1,261 an ounce.
Missed out on these gains? Don't worry because I'm tipping these hot stocks for big things over the next 12 months. Each of them could be just what you need to take your portfolio to the next level.
For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
If you’re expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you’ll be sorely disappointed. Not only are their dividends growing at a snail’s pace, their profits are under pressure too due to the increasing competitive environment.
The contrast to these “new breed” blue chips couldn’t be greater… especially the very real prospect of significant share price gains, something that’s looking less likely from the usual blue chip suspects.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.